pyrophosphate and phosphocitrate

The protection afforded by phosphocitrate, a phosphorylated polycarboxylic acid, against crystal-induced membrane damage to polymorphonuclear leukocytes was studied in vitro. Membranolysis was assessed by nitro blue tetrazolium salt reduction, lactate dehydrogenase release, and scanning electron microscopy. Phosphocitrate protected strongly against hydroxyapatite crystal-induced damage, an action attributable to crystal surface binding of phosphocitrate rather than to the membrane. The ability of phosphocitrate to prevent hydroxyapatite crystallization, together with its membrane protective effect against preformed crystals, would suggest that the compound might have a useful future role against crystal-induced arthropathies.

Topics: Apatites; Calcium Pyrophosphate; Cell Membrane; Citrates; Diphosphates; Humans; Microscopy, Electron; Neutrophils

The synthesis of N-sulfo-2-amino tricarballylate, a sulfamate analog of phosphocitrate, is described using pyridine-sulfur trioxide to sulfonate 2-amino tricarballylate. The product was purified using selective precipitation and chromatographic techniques and characterized by a variety of physical and chemical means. In particular, its ability to inhibit hydroxyapatite formation and calcium oxalate crystallization was assessed by comparison with known inhibitors including phosphocitrate and pyrophosphate. On the basis of these results, this new compound may ultimately have a role in preventing abnormal biological calcification.

Topics: Calcium; Calcium Oxalate; Citrates; Diphosphates; Durapatite; Hydroxyapatites; Structure-Activity Relationship; Tricarboxylic Acids